News Headlines Article

Medicare Coverage for Breast Cancer Drug Ends in Some States
New York Times

Breast cancer patients in some states may soon lose Medicare coverage for the expensive drug Avastin, after the Food and Drug Administration’s decision to revoke the drug’s approval for that disease.

Palmetto, one of the companies that determine Medicare coverage for different regions, said in a notice posted on its Web site that it would no longer pay for use of Avastin to treat breast cancer starting Jan. 29.